Budesonoid 200 mcg + Formeterol 0.6 mg

Jun 26, 2022

Introduction

R/C BUDEPRESS 200 is a combination inhalation therapy formulated for the effective management of asthma and chronic obstructive pulmonary disease (COPD). It contains Budesonide (200 mcg), a potent anti-inflammatory agent, and Formoterol (0.6 mcg), a long-acting bronchodilator that improves airflow and breathing efficiency. This dual-action formula helps control symptoms and prevent respiratory flare-ups.

Key Features and Ingredients

  • Budesonide (200 mcg): A corticosteroid that reduces inflammation, swelling, and mucus production in the airways, preventing asthma and COPD exacerbations.

  • Formoterol (0.6 mcg): A long-acting beta-agonist (LABA) that relaxes airway muscles, improving airflow and making breathing easier.

  • Dual-Action Formula: Ensures effective inflammation control and bronchodilation.

  • Inhalation-Based Therapy: Provides quick absorption for targeted respiratory relief.

  • Clinically Approved: Recommended for the long-term management of asthma and COPD.

Usage Instructions

  • Dosage: Typically prescribed as one to two inhalations twice daily, but the exact dosage should be determined by a doctor.

  • How to Use:

    • Shake the inhaler before use.

    • Exhale fully before inhaling the medication.

    • Place the inhaler mouthpiece in your mouth, take a deep breath, and press the canister to release the medication.

    • Hold your breath for a few seconds before exhaling.

  • Precautions:

    • Do not exceed the prescribed dose.

    • Rinse your mouth after use to prevent infections.

    • Consult a doctor if symptoms persist or worsen.

Benefits of R/C BUDEPRESS 200

  • Stronger Symptom Control: Helps prevent asthma attacks and COPD flare-ups.

  • Fast-Acting Bronchodilation: Provides quick relief from breathing difficulties.

  • Long-Lasting Effects: Each dose offers relief for up to 12 hours.

  • Reduces Airway Inflammation: Minimizes swelling and mucus production.

  • Improves Lung Function: Enhances oxygen intake and respiratory efficiency.

Frequently Asked Questions (FAQ)

1. Can R/C BUDEPRESS 200 be used for sudden asthma attacks?

No, this inhaler is not a rescue medication. For immediate relief, a short-acting bronchodilator like Salbutamol should be used.

2. What are the possible side effects?

Common side effects include throat irritation, dry mouth, headache, hoarseness, and mild tremors. Severe side effects should be reported to a doctor immediately.

3. Is R/C BUDEPRESS 200 suitable for children?

Yes, but only under medical supervision. The dosage may be adjusted based on age and severity of symptoms.

4. How quickly does this inhaler start working?

Initial symptom relief can be felt within a few minutes, with full therapeutic benefits developing over consistent use.

5. Can R/C BUDEPRESS 200 be used for long-term treatment?

Yes, it is safe for long-term management of asthma and COPD when used as prescribed by a doctor.

Conclusion

R/C BUDEPRESS 200 is a trusted and effective inhalation therapy for asthma and COPD management. With its dual-action formula, it provides long-lasting relief, improved lung function, and better respiratory control. If you experience persistent breathing difficulties, consult your doctor to determine if R/C BUDEPRESS 200 is the right choice for you.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

SHARE WITH